Copyright Reports & Markets. All rights reserved.

Global Breast Cancer Testing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Breast Cancer Testing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Screening Tests
      • 1.4.3 Diagnostic Tests
      • 1.4.4 Monitoring Tests
    • 1.5 Market by Application
      • 1.5.1 Global Breast Cancer Testing Market Share by Application (2019-2025)
      • 1.5.2 Non-invasive Breast Cancer
      • 1.5.3 Invasive Breast Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Breast Cancer Testing Market Size
    • 2.2 Breast Cancer Testing Growth Trends by Regions
      • 2.2.1 Breast Cancer Testing Market Size by Regions (2019-2025)
      • 2.2.2 Breast Cancer Testing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Breast Cancer Testing Market Size by by Players
      • 3.1.1 Global Breast Cancer Testing Revenue by by Players (2014-2019)
      • 3.1.2 Global Breast Cancer Testing Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Breast Cancer Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Breast Cancer Testing Key Players Head office and Area Served
    • 3.3 Key Players Breast Cancer Testing Product/Solution/Service
    • 3.4 Date of Enter into Breast Cancer Testing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Breast Cancer Testing Market Size by Type (2014-2019)
    • 4.2 Global Breast Cancer Testing Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Breast Cancer Testing Market Size (2014-2019)
    • 5.2 Breast Cancer Testing Key Players in North America
    • 5.3 North America Breast Cancer Testing Market Size by Type
    • 5.4 North America Breast Cancer Testing Market Size by Application

    6 Europe

    • 6.1 Europe Breast Cancer Testing Market Size (2014-2019)
    • 6.2 Breast Cancer Testing Key Players in Europe
    • 6.3 Europe Breast Cancer Testing Market Size by Type
    • 6.4 Europe Breast Cancer Testing Market Size by Application

    7 China

    • 7.1 China Breast Cancer Testing Market Size (2014-2019)
    • 7.2 Breast Cancer Testing Key Players in China
    • 7.3 China Breast Cancer Testing Market Size by Type
    • 7.4 China Breast Cancer Testing Market Size by Application

    8 Japan

    • 8.1 Japan Breast Cancer Testing Market Size (2014-2019)
    • 8.2 Breast Cancer Testing Key Players in Japan
    • 8.3 Japan Breast Cancer Testing Market Size by Type
    • 8.4 Japan Breast Cancer Testing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Breast Cancer Testing Market Size (2014-2019)
    • 9.2 Breast Cancer Testing Key Players in Southeast Asia
    • 9.3 Southeast Asia Breast Cancer Testing Market Size by Type
    • 9.4 Southeast Asia Breast Cancer Testing Market Size by Application

    10 India

    • 10.1 India Breast Cancer Testing Market Size (2014-2019)
    • 10.2 Breast Cancer Testing Key Players in India
    • 10.3 India Breast Cancer Testing Market Size by Type
    • 10.4 India Breast Cancer Testing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Breast Cancer Testing Market Size (2014-2019)
    • 11.2 Breast Cancer Testing Key Players in Central & South America
    • 11.3 Central & South America Breast Cancer Testing Market Size by Type
    • 11.4 Central & South America Breast Cancer Testing Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Breast Cancer Testing Introduction
      • 12.1.4 Abbott Revenue in Breast Cancer Testing Business (2014-2019))
      • 12.1.5 Abbott Recent Development
    • 12.2 Alere
      • 12.2.1 Alere Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Breast Cancer Testing Introduction
      • 12.2.4 Alere Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.2.5 Alere Recent Development
    • 12.3 Becton Dickinson
      • 12.3.1 Becton Dickinson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Breast Cancer Testing Introduction
      • 12.3.4 Becton Dickinson Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.3.5 Becton Dickinson Recent Development
    • 12.4 BioMerieux
      • 12.4.1 BioMerieux Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Breast Cancer Testing Introduction
      • 12.4.4 BioMerieux Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.4.5 BioMerieux Recent Development
    • 12.5 Roche
      • 12.5.1 Roche Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Breast Cancer Testing Introduction
      • 12.5.4 Roche Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.5.5 Roche Recent Development
    • 12.6 GE Healthcare
      • 12.6.1 GE Healthcare Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Breast Cancer Testing Introduction
      • 12.6.4 GE Healthcare Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.6.5 GE Healthcare Recent Development
    • 12.7 Hologic
      • 12.7.1 Hologic Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Breast Cancer Testing Introduction
      • 12.7.4 Hologic Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.7.5 Hologic Recent Development
    • 12.8 Philips
      • 12.8.1 Philips Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Breast Cancer Testing Introduction
      • 12.8.4 Philips Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.8.5 Philips Recent Development
    • 12.9 PerkinElmer
      • 12.9.1 PerkinElmer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Breast Cancer Testing Introduction
      • 12.9.4 PerkinElmer Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.9.5 PerkinElmer Recent Development
    • 12.10 Quest Diagnostics
      • 12.10.1 Quest Diagnostics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Breast Cancer Testing Introduction
      • 12.10.4 Quest Diagnostics Revenue in Breast Cancer Testing Business (2014-2019)
      • 12.10.5 Quest Diagnostics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected of having breast cancer (such as biopsies).These tests are used to determine whether breast cancer is present and, if so, whether it has reached the outside of the breast.Diagnostic tests are also used to gather more information about cancer to guide treatment decisions.Once breast cancer is diagnosed, many tests are used during and after treatment to monitor how well therapies are working. Monitoring tests also may be used to check for any signs of recurrence.
      In 2018, the global Breast Cancer Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Breast Cancer Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Abbott
      Alere
      Becton Dickinson
      BioMerieux
      Roche
      GE Healthcare
      Hologic
      Philips
      PerkinElmer
      Quest Diagnostics

      Market segment by Type, the product can be split into
      Screening Tests
      Diagnostic Tests
      Monitoring Tests

      Market segment by Application, split into
      Non-invasive Breast Cancer
      Invasive Breast Cancer

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Breast Cancer Testing status, future forecast, growth opportunity, key market and key players.
      To present the Breast Cancer Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Breast Cancer Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now